Pfizer (NY:PFE)

27.23 -0.22 (-0.82%)

Streaming Delayed Price Updated: 11:03 AM EDT, Mar 18, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Pfizer

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

The High-Stakes Gambit: How Healthcare Giants are 'Front-Loading' Megadeals to Outrun Regulatory Storms

Today 10:16 EDT

In the face of the most aggressive antitrust environment in decades and the sweeping legislative changes of the 2025 "One Big Beautiful Bill Act" (OBBBA), the healthcare sector has not retreated from...

Via MarketMinute

Topics Artificial Intelligence Intellectual Property

The Best Healthcare Stocks to Buy With $50 Right Now ↗

Today 8:50 EDT

Even on a budget, you can get quality stocks.

Via The Motley Fool

Tuesday's session: most active stock in the S&P500 index ↗

March 17, 2026

Via Chartmill

The Grand Divergence: Finance Surges as Health Care Braces for a Historic Q1 Earnings Slump

March 17, 2026

As the first quarter of 2026 draws to a close, the S&P 500 is witnessing one of the most dramatic sector performance splits in recent financial history. According to consensus estimates as of March 17,...

Via MarketMinute

Topics Earnings Economy Initial Public Offering

Pfizer Touts Promising Survival Data Without Worsening For Advanced Breast Cancer Patients ↗

March 17, 2026

Pfizer trial results for a new breast cancer treatment showed improved progression-free survival and a manageable safety profile.

Via Benzinga

Pfizer Announces Positive Topline Phase 2 Results for Next-Generation CDK4 Inhibitor, Atirmociclib, in Second-Line Metastatic Breast Cancer

March 17, 2026

From Pfizer Inc.

Via Business Wire

Should You Avoid Pfizer? Here's the Key Risk to Watch ↗

March 17, 2026

Pfizer has reached a turning point.

Via The Motley Fool

Topics Intellectual Property

1 Cash-Producing Stock to Target This Week and 2 That Underwhelm

March 17, 2026

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff...

Via StockStory

The mRNA Renaissance: Moderna’s 83% Surge Leads the 2026 Healthcare Recovery

March 16, 2026

The biotech sector has found its new North Star in 2026. As of mid-March, Moderna Inc. (NASDAQ: MRNA) has shocked Wall Street with a staggering 83% year-to-date gain, catapulting it to the upper...

Via MarketMinute

Topics Artificial Intelligence Initial Public Offering Stocks

VCIT Offers Broader Diversification Than FIGB ↗

March 16, 2026

Explore how differences in cost, risk, and portfolio breadth could impact your choice between these two bond ETFs.

Via The Motley Fool

Topics Bonds ETFs

Rushing Headlong: Health IT's Legacy and the Road to Responsible AI Named 2025 Foreword INDIES Book of the Year Awards Finalist

March 16, 2026

Via PRLog

Topics Artificial Intelligence

Merck & Co. Trades Ex-Dividend as Healthcare Emerges as a Volatility Hedge in 2026

March 16, 2026

Amidst a backdrop of mounting geopolitical tensions and sharp swings in the broader indices, pharmaceutical giant Merck & Co. (NYSE: MRK) officially trades ex-dividend today, March 16, 2026. Investors...

Via MarketMinute

Topics Artificial Intelligence Economy Intellectual Property

3 Monster Dividend Stocks to Hold for the Next 10 Years ↗

March 16, 2026

These dividend stocks are built for the long haul.

Via The Motley Fool

Topics Artificial Intelligence Energy

The Stock Market May Be Shifting From Risky Tech Stocks to Safer Sectors. Here Are 3 Stocks to Buy Before They Soar. ↗

March 15, 2026

Plenty of companies do just fine regardless of the economic environment.

Via The Motley Fool

Topics Artificial Intelligence Economy

Explore the S&P500 index on Friday and find out which stocks are the most active in today's session. ↗

March 13, 2026

Via Chartmill

1 Magnificent Dividend Stock Down 57% to Buy and Hold Forever ↗

March 13, 2026

This healthcare giant is trading at a discounted price today.

Via The Motley Fool

Topics Intellectual Property

2 Healthcare Stocks with Solid Fundamentals and 1 Facing Challenges

March 13, 2026

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have se...

Via StockStory

Starboard Value Is Betting Big on This Blue-Chip Dividend Stock. Should You?

March 12, 2026

Starboard does not have a stellar recent record, and Lamb Weston is facing its own issues. Here's what investors need to know about Lamb Weston.

Via Barchart.com

Complementing the Future: A Deep Dive into Dianthus Therapeutics (DNTH) After Its Phase 3 Breakthrough

March 12, 2026

Date: March 12, 2026 Introduction Dianthus Therapeutics (NASDAQ: DNTH) has become the center of Wall Street’s attention today, with its share price surging 19.4% in early trading following a pivotal...

Via Finterra

Topics Economy

The Azetukalner Breakthrough: A Deep Dive into Xenon Pharmaceuticals (XENE)

March 12, 2026

Date: March 12, 2026Sector: Biotechnology / NeurologyMarket Cap: ~$4.8 Billion Introduction On March 9, 2026, the neurology sector of the biotechnology market witnessed a seismic shift. Xenon...

Via Finterra

Topics ETFs Intellectual Property

The Best Covered Call Strategy to Trade High-Yielding Pfizer Stock and Earn Extra Income

March 12, 2026

Income investors tend to gravitate towards covered calls, and blue-chip high yielding stocks are a great place to start. Pfizer (PFE) has been a strong performer in 2026 and is up 9.64% so far this...

Via Barchart.com

Stay informed about the most active stocks in the S&P500 index on Wednesday's session. ↗

March 11, 2026

Via Chartmill

Why BridgeBio Leapfrogged Its 50-Day Line On Pfizer's Patent Shake-Up ↗

March 10, 2026

Shares popped Tuesday on a notable shake-up in the patent battle surrounding Pfizer's rival drug, tafamidis.

Via Investor's Business Daily

Topics Intellectual Property

2 Healthcare Stocks That Are Too Cheap to Ignore ↗

March 10, 2026

These companies' shares have fallen too far, offering investors an attractive opportunity.

Via The Motley Fool

BioNTech Navigates Post-Pandemic Deficit: A €17 Billion Bet on the Oncology Frontier

March 10, 2026

In a watershed moment for the biotechnology sector, BioNTech SE (NASDAQ: BNTX) has reported its full-year 2025 financial results, signaling the definitive end of the COVID-19 vaccine gold rush and the...

Via MarketMinute

Pfizer (PFE) 2026 Research Feature: The High-Stakes Pivot to Oncology and Obesity

March 10, 2026

As of today, March 10, 2026, Pfizer Inc. (NYSE: PFE) stands at a pivotal crossroads in its 177-year history. After experiencing a meteoric rise during the COVID-19 pandemic followed by a sobering...

Via Finterra

Topics Economy Intellectual Property Lawsuit

The Potassium Channel Breakthrough: A Deep-Dive on Xenon Pharmaceuticals (XENE)

March 10, 2026

As of March 10, 2026, the biopharmaceutical sector is witnessing a historic realignment in the neurology space, spearheaded by the Canadian-born clinical powerhouse Xenon Pharmaceuticals Inc. (Nasdaq:...

Via Finterra

Topics Economy Initial Public Offering Intellectual Property

3 Healthcare Stocks Paying the Highest Dividends of 2026 ↗

March 10, 2026

A handful of the industry's income-generating gems are hiding in plain sight.

Via The Motley Fool

1 S&P 500 Stock with Promising Prospects and 2 We Avoid

March 10, 2026

The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all ...

Via StockStory

Topics Stocks

Looking for the most active stocks in the S&P500 index on Monday? ↗

March 09, 2026

Via Chartmill

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.